EQ-5D-5L Measurement in Bulgarian Community Pharmacies: A Cross-Sectional Study of Published Patient Data and a New Pharmacist Survey to Inform a Prospective Feasibility Study
Bulgaria lacks routine EQ-5D-5L data collection and a national value set, so domestic health technology assessment relies on imported utility values. This study evaluated whether existing evidence justifies a feasibility study of routine EQ-5D-5L measurement in community pharmacies. In this cross-sectional study, reported according to STROBE, we analysed secondary data from a previously published pharmacy-based patient survey and primary data from a new pharmacist survey on questionnaire-based mental health screening, and used both to specify its design. In the source study (n = 119), complete EQ-5D-5L data were obtained from all enrolled participants (mean utility 0.72, 95% CI 0.679–0.756), with directionally consistent known-groups differences; the number of patients approached, administration time and acceptability were not reported. Among surveyed pharmacists (n = 105; convenience sample, response rate not calculable), 80.0% would undertake training and 75.2% would participate in a screening service given clear referral procedures; leading constraints were lack of confidential space (79.0%), time (64.8%) and trained staff (56.2%). Familiarity with PHQ-9/GAD-7 was associated with greater willingness (risk difference 20.5 percentage points, 95% CI 3.9–35.9). EQ-5D-5L-specific readiness was not assessed. Because key feasibility parameters are unknown, a prospective multicentre feasibility study is justified; its endpoints and provisional progression criteria are specified.
Authors
- Hristo Krastev (ORCID: https://orcid.org/0009-0005-7974-7397)
- Yoanna Vutova (ORCID: https://orcid.org/0009-0006-0103-5805)
- S. Djambazov (ORCID: https://orcid.org/0000-0002-9224-9588)
- Slavchev, Georgi; HTA Ltd., Sofia, Bulgaria
- Svetlin Georgiev
Institutions
- Medical University of Sofia (BG)
Publication Details
- Journal
- Pharmacy
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3390/pharmacy14080171
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00